Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.14 USD | +4.71% | +0.71% | +129.53% |
Financials (USD)
Sales 2024 * | 2.3M | Sales 2025 * | 1.47M | Capitalization | 847M |
---|---|---|---|---|---|
Net income 2024 * | -123M | Net income 2025 * | -153M | EV / Sales 2024 * | 306 x |
Net cash position 2024 * | 143M | Net cash position 2025 * | 63.12M | EV / Sales 2025 * | 532 x |
P/E ratio 2024 * |
-5.83
x | P/E ratio 2025 * |
-5.36
x | Employees | 82 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.83% |
Latest transcript on Praxis Precision Medicines, Inc.
1 day | +4.71% | ||
1 week | +0.71% | ||
Current month | -16.19% | ||
1 month | -5.07% | ||
3 months | +37.51% | ||
6 months | +204.40% | ||
Current year | +129.53% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Petrou
FOU | Founder | - | 15-09-21 |
Marcio Souza
CEO | Chief Executive Officer | 45 | 20-03-31 |
Director of Finance/CFO | 51 | 21-05-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
CHM | Chairman | 68 | 20-09-16 |
William Young
BRD | Director/Board Member | 79 | 16-11-30 |
Gregory Norden
BRD | Director/Board Member | 66 | 19-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 2 M€ | -.--% | ||
0.00% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 51.14 | +4.71% | 197,326 |
24-04-23 | 48.84 | +2.22% | 246,522 |
24-04-22 | 47.78 | +1.90% | 662,450 |
24-04-19 | 46.89 | +0.64% | 350,086 |
24-04-18 | 46.59 | -8.25% | 204,311 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+129.53% | 847M | |
+4.09% | 43.84B | |
+46.28% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- PRAX Stock